EMA
withdrawal
· 2009-12-31
EMA Refused: Rhucin (recombinant human C1-inhibitor) — Pharming Group N.V.
Summary
The EMA refused approval for Rhucin (recombinant human C1-inhibitor) by Pharming Group N.V. for angioedema, decision dated 31 December 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Refused. Therapeutic area: Angioedema. MAH: Pharming Group N.V.. Decision date: 31/12/2009